JP2008513510A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008513510A5 JP2008513510A5 JP2007532670A JP2007532670A JP2008513510A5 JP 2008513510 A5 JP2008513510 A5 JP 2008513510A5 JP 2007532670 A JP2007532670 A JP 2007532670A JP 2007532670 A JP2007532670 A JP 2007532670A JP 2008513510 A5 JP2008513510 A5 JP 2008513510A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- formula
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010040984 Sleep disease Diseases 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
Claims (5)
- 式：
- 化合物は、
- 式：
- 請求項１〜３のいずれか１項に記載の化合物と、少なくとも１種の医薬的に許容しうる賦形剤とを含む医薬組成物。
- 睡眠障害を治療するための、請求項１〜３のいずれか１項に記載の化合物、またはその医薬的に許容しうる塩を含む医薬組成物。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61184904P | 2004-09-21 | 2004-09-21 | |
| US60/611,849 | 2004-09-21 | ||
| US67319805P | 2005-04-19 | 2005-04-19 | |
| US60/673,198 | 2005-04-19 | ||
| PCT/US2005/034015 WO2006034414A2 (en) | 2004-09-21 | 2005-09-21 | Loxapine analogs and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008513510A JP2008513510A (ja) | 2008-05-01 |
| JP2008513510A5 true JP2008513510A5 (ja) | 2011-01-06 |
| JP5049129B2 JP5049129B2 (ja) | 2012-10-17 |
Family
ID=36090680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532670A Expired - Fee Related JP5049129B2 (ja) | 2004-09-21 | 2005-09-21 | ロキサピン類縁体およびそれらの使用方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US7592333B2 (ja) |
| EP (1) | EP1804804B1 (ja) |
| JP (1) | JP5049129B2 (ja) |
| KR (1) | KR101264444B1 (ja) |
| AT (1) | ATE542536T1 (ja) |
| AU (1) | AU2005286713B2 (ja) |
| BR (1) | BRPI0515518A (ja) |
| CA (1) | CA2580250C (ja) |
| CY (1) | CY1112590T1 (ja) |
| DK (1) | DK1804804T3 (ja) |
| EA (1) | EA012610B1 (ja) |
| ES (1) | ES2378452T3 (ja) |
| MA (1) | MA28985B1 (ja) |
| MX (1) | MX2007003032A (ja) |
| NO (1) | NO20071604L (ja) |
| NZ (1) | NZ553900A (ja) |
| PL (1) | PL1804804T3 (ja) |
| PT (1) | PT1804804E (ja) |
| WO (1) | WO2006034414A2 (ja) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US20050250767A1 (en) * | 2003-01-23 | 2005-11-10 | Weiner David M | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| AU2004206931A1 (en) * | 2003-01-23 | 2004-08-05 | Acadia Pharmaceuticals Inc. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| US20050085463A1 (en) * | 2003-01-23 | 2005-04-21 | Weiner David M. | Use of N-desmethylclozapine to treat human neuropsychiatric disease |
| DE602004020263D1 (de) * | 2003-12-22 | 2009-05-07 | Acadia Pharm Inc | Amino-substituierte diaryläa,dücyclohepten- analoga als muscarinische agonisten und verfahren zur behandlung von neuropsychiatrischen erkrankungen |
| JP2007536216A (ja) * | 2004-04-01 | 2007-12-13 | アカディア ファーマシューティカルズ，インコーポレーテッド | 固体ｎ−デスメチルクロザピンおよびその結晶形を合成および単離する方法 |
| US7563785B2 (en) * | 2004-10-29 | 2009-07-21 | Hypnion, Inc. | Quetiapine analogs and methods of use thereof |
| US20070105836A1 (en) * | 2005-10-31 | 2007-05-10 | Lars Pettersson | Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| US7762006B2 (en) * | 2006-06-14 | 2010-07-27 | Siestamed, Technologies | Medical equipment drying device |
| CN101573333B (zh) * | 2006-10-28 | 2013-06-12 | 梅特希尔基因公司 | 组蛋白脱乙酰酶抑制剂 |
| RU2469033C2 (ru) * | 2007-03-15 | 2012-12-10 | Арикс Терапьютикс, Инк. | СОЕДИНЕНИЯ ДИБЕНЗО[b,f][1,4]ОКСАЗАПИНА |
| US8622991B2 (en) | 2007-03-19 | 2014-01-07 | Insuline Medical Ltd. | Method and device for drug delivery |
| WO2008114223A1 (en) | 2007-03-19 | 2008-09-25 | Insuline Medical Ltd. | Drug delivery device |
| US9220837B2 (en) | 2007-03-19 | 2015-12-29 | Insuline Medical Ltd. | Method and device for drug delivery |
| EP2231229A1 (en) | 2007-12-18 | 2010-09-29 | Insuline Medical Ltd. | Drug delivery device with sensor for closed-loop operation |
| CA2743027C (en) | 2008-11-07 | 2016-04-12 | Insuline Medical Ltd. | Device and method for drug delivery |
| WO2014116684A1 (en) * | 2013-01-22 | 2014-07-31 | Edward Roberts | Non-peptidic neuropeptide y receptor modulators |
| WO2016154028A1 (en) | 2015-03-26 | 2016-09-29 | Iversen Jacqueline M | Methods and compositions to inhibit symptoms associated with veisalgia |
| IL292370A (en) | 2019-10-21 | 2022-06-01 | Alairion Inc | Pimerazine-converted azapine histories and their uses |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL140242B (nl) * | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
| US3928356A (en) * | 1967-10-06 | 1975-12-23 | Fujisawa Pharmaceutical Co | 10-{8 4-({107 -Hydroxy alkyl)-1-piperazimyl{9 -dibenzo (h,f) oxofins and thiepins and acetyl esters thereof |
| NL7110453A (ja) | 1970-08-06 | 1972-02-08 | Wander Ag Dr A | |
| US4072756A (en) * | 1973-05-17 | 1978-02-07 | Sandoz Ltd. | Tricyclo piperidino ketones and soporific compositions thereof |
| US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
| US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| JPH04211071A (ja) * | 1990-03-05 | 1992-08-03 | Hokuriku Seiyaku Co Ltd | 多環式化合物 |
| US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
| CA2166891C (en) | 1993-07-09 | 2001-07-03 | Sang K. Wong | Method for making freeze dried drug dosage forms |
| US5895664A (en) | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
| US5622719A (en) | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
| US5616344A (en) | 1994-06-14 | 1997-04-01 | Fuisz Technologies Ltd. | Apparatus and process for strengthening low density compression dosage units and product therefrom |
| US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
| AR008371A1 (es) | 1996-05-30 | 2000-01-19 | Novartis Ag | Una sal de adicion con acido de una 10-aminoalifatil-dibenz[b,f],oxepina, su empleo; procedimiento para su elaboracion, una 10-aminoalifatil-dibenz[b,f]oxepina, una preparacion farmaceutica que contiene dicha sal o dicha oxepina y un procedimiento para el tratamiento de enfermedades neurodegenerativ |
| AU736912B2 (en) | 1997-02-20 | 2001-08-02 | Therics, Inc. | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
| US6277406B1 (en) | 1997-10-08 | 2001-08-21 | Fuisz Technologies Ltd. | Easily processed tablet compositions |
| US7355042B2 (en) * | 2001-10-16 | 2008-04-08 | Hypnion, Inc. | Treatment of CNS disorders using CNS target modulators |
| US7189757B2 (en) * | 2001-10-16 | 2007-03-13 | Hypnion, Inc. | Treatment of sleep disorders using CNS target modulators |
| WO2003039255A1 (en) | 2001-11-05 | 2003-05-15 | Basf Aktiengesellschaft | Use of substituted dibenzothiepine derivatives as insecticidal, acaricidal and nematicidal agents |
| EP1578198A1 (en) * | 2002-12-20 | 2005-09-28 | Basf Aktiengesellschaft | Pesticidal dibenzo(hetero)azepine derivatives |
| US20060063754A1 (en) * | 2004-09-21 | 2006-03-23 | Edgar Dale M | Methods of treating a sleep disorder |
-
2005
- 2005-09-21 JP JP2007532670A patent/JP5049129B2/ja not_active Expired - Fee Related
- 2005-09-21 BR BRPI0515518-5A patent/BRPI0515518A/pt not_active IP Right Cessation
- 2005-09-21 US US11/233,417 patent/US7592333B2/en not_active Expired - Fee Related
- 2005-09-21 NZ NZ553900A patent/NZ553900A/en not_active IP Right Cessation
- 2005-09-21 MX MX2007003032A patent/MX2007003032A/es active IP Right Grant
- 2005-09-21 ES ES05801120T patent/ES2378452T3/es active Active
- 2005-09-21 DK DK05801120.6T patent/DK1804804T3/da active
- 2005-09-21 US US11/232,590 patent/US20060063755A1/en not_active Abandoned
- 2005-09-21 WO PCT/US2005/034015 patent/WO2006034414A2/en active Application Filing
- 2005-09-21 AT AT05801120T patent/ATE542536T1/de active
- 2005-09-21 PL PL05801120T patent/PL1804804T3/pl unknown
- 2005-09-21 KR KR1020077009122A patent/KR101264444B1/ko not_active IP Right Cessation
- 2005-09-21 CA CA2580250A patent/CA2580250C/en not_active Expired - Fee Related
- 2005-09-21 EA EA200700702A patent/EA012610B1/ru not_active IP Right Cessation
- 2005-09-21 AU AU2005286713A patent/AU2005286713B2/en not_active Ceased
- 2005-09-21 PT PT05801120T patent/PT1804804E/pt unknown
- 2005-09-21 EP EP05801120A patent/EP1804804B1/en active Active
-
2007
- 2007-03-20 MA MA29765A patent/MA28985B1/fr unknown
- 2007-03-27 NO NO20071604A patent/NO20071604L/no not_active Application Discontinuation
-
2009
- 2009-03-25 US US12/411,083 patent/US8101596B2/en not_active Expired - Fee Related
-
2012
- 2012-03-28 CY CY20121100315T patent/CY1112590T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008513510A5 (ja) | ||
| JP2006526031A5 (ja) | ||
| JP2005518413A5 (ja) | ||
| JP2009545527A5 (ja) | ||
| JP2007522220A5 (ja) | ||
| JP2009502743A5 (ja) | ||
| JP2009502793A5 (ja) | ||
| JP2003503454A5 (ja) | ||
| JP2008517059A5 (ja) | ||
| JP2007514005A5 (ja) | ||
| JP2008539268A5 (ja) | ||
| JP2008539267A5 (ja) | ||
| JP2010526777A5 (ja) | ||
| JP2012502037A5 (ja) | ||
| JP2012532874A5 (ja) | ||
| JP2007145875A5 (ja) | ||
| JP2009511595A5 (ja) | ||
| WO2006098918A3 (en) | Substituted gamma lactams as therapeutic agents | |
| IL167900A (en) | Use of betamimetics to prepare a medical preparation for the treatment of chronic obstructive pulmonary disease | |
| JP2014507446A5 (ja) | ||
| JP2007520565A5 (ja) | ||
| JP2004534850A5 (ja) | ||
| JP2008515980A5 (ja) | ||
| JP2010504343A5 (ja) | ||
| JP2010518061A5 (ja) |